K. Ishige

发表

A case report: Long-term complete response of metastatic hepatocellular carcinoma obtained after discontinuation of 2-month sorafenib monotherapy

I. Hyodo, Suguru Hirose, K. Ishige, 2020, Clinical Journal of Gastroenterology.

Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide

I. Hyodo, M. Shiigai, M. Minami, 2019, Japanese Journal of Radiology.

Nuclear factor (erythroid derived 2)-like 2 activation increases exercise endurance capacity via redox modulation in skeletal muscles

T. Iwawaki, E. Warabi, Y. Miwa, 2017, Scientific Reports.

Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.

I. Hyodo, Masayuki Yamamoto, T. Yanagawa, 2010, American journal of physiology. Gastrointestinal and liver physiology.

Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic options

H. Sugiyama, K. Ishige, J. Shoda, 2012, Journal of hepato-biliary-pancreatic sciences.

Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder

Masakazu Yamamoto, M. Yamato, H. Sugiyama, 2014, Journal of Gastroenterology.

Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice

Masakazu Yamamoto, Satoru Takahashi, T. Yanagawa, 2020, Experimental animals.

Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status

I. Hyodo, Yoshiyuki Yamamoto, M. Nishi, 2014, Medical Oncology.

Simultaneous occurrence of prostate cancer and IgE myeloma, a rare hematolymphoid malignancy

H. Ito, T. Igarashi, K. Ishige, 2000, International Journal of Clinical Oncology.

Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma

I. Hyodo, Yoshiyuki Yamamoto, Suguru Hirose, 2020, Internal medicine.

Potent in vitro and in vivo antitumor activity of interleukin‐4‐conjugated Pseudomonas exotoxin against human biliary tract carcinoma

R. Puri, N. Ohkohchi, I. Hyodo, 2008, International journal of cancer.

Interleukin-4 receptor α-based hybrid peptide effectively induces antitumor activity in head and neck squamous cell carcinoma.

H. Bukawa, T. Yanagawa, E. Warabi, 2013, Oncology reports.

The prevalence and clinical implications of pancreatic fat accumulation identified during a medical check-up

H. Nishiyama, K. Ishige, J. Shoda, 2021, Medicine.

Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease

T. Isobe, H. Iijima, K. Akiyama, 2018, Journal of Gastroenterology.

Percutaneous transhepatic obliteration-related procedures for isolated gastric varices: experience of three cases

K. Tsuchiya, Suguru Hirose, K. Ishige, 2021, Clinical Journal of Gastroenterology.

Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy.

T. Horibe, K. Kawakami, K. Kita, 2012, Oncology letters.

A Case of Long-Term Survival with Own Liver in the Patient of Biliary Atresia Who Developed Hepatocellular Carcinoma

K. Masumoto, H. Takayasu, K. Ishige, 2020 .

Exercise training enhances in vivo clearance of endotoxin and attenuates inflammatory responses by potentiating Kupffer cell phagocytosis

T. Yanagawa, E. Warabi, K. Akiyama, 2017, Scientific Reports.

Splenic rupture caused by pancreatic pseudocyst successfully treated by endoscopic ultrasound-guided drainage

I. Hyodo, Yoshimi Ito, K. Ishige, 2020, Clinical Journal of Gastroenterology.

MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.

T. Irimura, N. Ohkohchi, S. Krishnamurthy, 2008, European journal of cancer.

Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients.

I. Wistuba, M. Thomas, Donghui Li, 2015, Molecular and clinical oncology.

Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab

Masakazu Yamamoto, M. Thomas, S. Ariizumi, 2015, Journal of Gastroenterology.

Usefulness of argon plasma coagulation for bleeding around hepaticojejunal anastomosis

Yoshiyuki Yamamoto, Hideo Suzuki, K. Ishige, 2021, DEN open.

An autopsy case of non‐traumatic fat embolism syndrome

M. Noguchi, I. Hyodo, S. Sakashita, 2017, Pathology international.

Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic‐Phase Chronic Myeloid Leukemia

N. Takahashi, M. Miura, Y. Miyazaki, 2010, Clinical pharmacology and therapeutics.

Nuclear factor (erythroid derived 2)-like 2 activation increases exercise endurance capacity via redox modulation in skeletal muscles

T. Iwawaki, E. Warabi, Y. Miwa, 2017, Scientific Reports.

Haematological remission and bone healing of refractory plasma cell leukaemia by chronic oral etoposide

K. Ishige, C. Sakai, T. Takagi, 1995, European journal of haematology.

Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma

I. Hyodo, H. Ishikawa, H. Sakurai, 2017, Cancer science.

A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma

T. Hashimoto, T. Sakae, I. Hyodo, 2013, Radiation Oncology.

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy

T. Nonaka, H. Ishikawa, H. Sakurai, 2019, Radiation Oncology.

Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells

Masakazu Yamamoto, M. Yamato, H. Sugiyama, 2011, Journal of Gastroenterology.

Proton Beam Therapy for Hepatocellular Carcinoma after the Fontan Procedure

H. Sakurai, N. Fukumitsu, T. Okumura, 2021, Journal of Cancer Therapy.

Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis

Masakazu Yamamoto, T. Yanagawa, E. Warabi, 2017, Experimental animals.

A case of pancreatic-pleural fistula of Type 1 autoimmune pancreatitis successfully treated with pancreatic drainage and steroid

I. Hyodo, K. Ishige, Junji Hattori, 2020, Clinical Journal of Gastroenterology.

Survival analysis of platinum-refractory patients with advanced esophageal cancer treated with docetaxel or best supportive care alone: a retrospective study.

I. Hyodo, Yoshiyuki Yamamoto, T. Matsumoto, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Proton beam therapy for hepatocellular carcinoma with bile duct invasion

M. Takahashi, K. Nakai, T. Okumura, 2023, BMC Gastroenterology.

A Transarterial Chemoembolization of Balloon-Occluded Alternate Infusions of Cisplatin and Gelatin Particles for Hepatocellular Carcinoma: A Phase I/II Multicenter Prospective Study of Safety and Efficacy.

K. Ishige, N. Hasegawa, Kuniaki Fukuda, 2021, Journal of vascular and interventional radiology : JVIR.

MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.

T. Irimura, N. Ohkohchi, S. Krishnamurthy, 2008, European journal of cancer.

Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice

F. Sugiyama, E. Warabi, Kanako Kato, 2020 .

Potent in vitro and in vivo antitumor activity of interleukin‐4‐conjugated Pseudomonas exotoxin against human biliary tract carcinoma

R. Puri, N. Ohkohchi, I. Hyodo, 2008, International journal of cancer.

Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease

T. Isobe, H. Iijima, K. Akiyama, 2018, Journal of Gastroenterology.